CSAM Health Group AS
CSAMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $425 | $410 | $367 | $329 |
| % Growth | 3.5% | 11.9% | 11.3% | – |
| Cost of Goods Sold | $31 | $32 | $33 | $35 |
| Gross Profit | $394 | $378 | $333 | $294 |
| % Margin | 92.7% | 92.2% | 90.9% | 89.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $20 | $23 | $15 |
| SG&A Expenses | $0 | $21 | $25 | $18 |
| Sales & Mktg Exp. | $0 | $2 | $3 | $3 |
| Other Operating Expenses | $397 | $228 | $398 | $318 |
| Operating Expenses | $397 | $250 | $424 | $336 |
| Operating Income | -$3 | $129 | -$90 | -$42 |
| % Margin | -0.7% | 31.4% | -24.7% | -12.7% |
| Other Income/Exp. Net | -$57 | -$25 | -$46 | -$47 |
| Pre-Tax Income | -$60 | $103 | -$136 | -$89 |
| Tax Expense | -$1 | -$8 | -$5 | -$3 |
| Net Income | -$59 | $104 | -$132 | -$87 |
| % Margin | -14% | 25.4% | -35.9% | -26.3% |
| EPS | -2.94 | 5.11 | -6.29 | -4.13 |
| % Growth | -157.5% | 181.2% | -52.3% | – |
| EPS Diluted | -2.94 | 5.11 | -6.29 | -4.13 |
| Weighted Avg Shares Out | 20 | 20 | 21 | 21 |
| Weighted Avg Shares Out Dil | 20 | 20 | 21 | 21 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $25 | $2 | -$21 |
| Interest Expense | $60 | $50 | $37 | $27 |
| Depreciation & Amortization | $56 | -$65 | $89 | $84 |
| EBITDA | $56 | $225 | -$10 | $21 |
| % Margin | 13.2% | 54.7% | -2.8% | 6.4% |